Abstract:Objective To analyze the characteristics of dynamic blood glucose in hypoglycemia patients with different causes and explore the application value of dynamic glucose monitoring system (DGMS) in the diagnosis and differential diagnosis of hypoglycemia.Methods We used DGMS to monitor the blood glucose levels of 20 hypoglycemia patients for 3-6 days,including 6 cases of insulinoma,7 cases of reactive hypoglycemia,2 cases of autoimmune hypoglycemia,3 cases of islet cell hyperplasia,1 case of drug-induced hypoglycemia,1 case of congenital hyperinsulinism.The blood glucose profiles of hypoglycemia patients with different causes were compared.Results The average monitoring duration was (88.9 ± 10.8) hours.38-936 points of hypoglycemia were detected in these patients with hypoglycemia.The average blood glucose of patients of each cause,in the order from low to high,were:congenital hyperinsulinism [(2.97 ± 0.59) mmol/L],islet cell hyperplasia [(4.83 ± 1.32) mmol/L],insulinoma [(4.87 ± 1.37) mmol/L],drug-induced hypoglycemia [(5.98 ±0.8) mmol/L],reactive hypoglycemia [(6.38 ± 1.99) mmol/L],and autoimmune hypoglycemia [(7.63 ± 2.67) mmol/L].The constituent ratio of hypoglycemia from low to high were:autoimmune hypoglycemia and drug-induced hypoglycemia (0％),reactive hypoglycemia [0.5％ (0.0％,1.6％),insulinoma [9.0％ (5.2％,16.3％),islet cell hyperplasia [9.5％ (1.1％,14.2％),congenital hyperinsulinism (58.5％).In terms of the blood glucose profiles in day and night,the night blood glucose levels were lower than those in daytime in insulinoma [(5.16 ± 1.37) mmol/L vs.(4.44 ± 1.24) mmol/L],reactive hypoglycemia [(6.93 ±2.19) mmol/L vs.(5.57 ±1.25) mmol/L],autoimmune hypoglycemia [(8.08 ± 2.79) mmol/L vs.(6.95 ± 2.31) mmol/L],islet cell hyperplasia [(5.23 ± 1.31) mmol/L vs.(4.11 ± 1.00) mmol/L] and congenital hyperinsulinism [(3.06 ±0.57) mmol/L vs.(2.83 ±0.59) mmol/L] (all P ＜ 0.05);while the daytime blood glucose level was lower than that at night in drug-induced hypoglycemia [(5.90 ±0.81) mmol/L vs.(6.11 ±0.77) mmol/L,P ＜0.05].62.2％ and 78.9％ of the hypoglycemia episodes happened at night in patients with insulinoma and islet cell hyperplasia,and 43.2％ at night in patients with congenital hyperinsulinism.The highest standard deviation of blood glucose (2.67 mmol/L),largest amplitude of glycemic excursions (9.2 mmol/L) and coefficient of variation (35％) were found in patients with autoimmune hypoglycemia.The largest range of blood glucose (20.4 mmol/L) was found in patients with reactive hypoglycemia.The day-night differences in coefficient of variation (31.6％ vs.22.4％) and range of blood glucose (20.4 mmol/L vs.6.8 mmol/L) were most prominent in patients with reactive hypoglycemia.Conclusion The dynamic monitoring of blood glucose and the analysis of the parameters such as average blood glucose,blood glucose profiles and variability of blood glucose may be helpful for the diagnosis of hypoglycemia and differential diagnosis of causes of hypoglycemia.

Continuous Glucose Monitoring of 54 Diabetic Patients after Different Treatments

Clinical observation and nursing care on patients with type 2 diabetes applied as continuous subcutaneous insulin infusion

Changes of Blood Pressure,blood Glucose and Blood Lipids Levels after Intensive Treatment in Incipient Diabetes II Patients

Application of Dynamic Glucose Monitoring in the Diagnosis and Differential Diagnosis of Hypoglycemia

Control of Blood Glucose Fluctuation by Real-Time Continuous Glucose Monitoring in Type 2 Diabetes

Comparison of the effect of different short-term intensive anti-diabetic therapies on newly diagnosed type 2 diabetic patients.

Effect of standardized intensive insulin therapy guideline on glucose fluctuation in type 2 diabetes inpatients

Effect of treating hyperglycemia of type 2 diabetes with continuous subcutaneous insulin infusion

The Comparison of the Β-Cell Function Between Continuous Subcutaneous Insulin Infusion and Multiple Daily Infusion on Newly Diagnosed Type 2 Diabetic Patients Given Short-term Intensive Therapy

PDG8 EFFICACY OF PHARMACOLOGICAL MONOTHERAPIES FOR TYPE 2 DIABETES IN CHINA

Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial

The Effects of Continuous Subcutaneous Insulin Infusion on Metabolism of Glucose and Lipid in Patients with Type 2 Diabetes

Effect of regular intensive therapy with insulin pump on beta cell function in newly diagnosed type 2 diabetes mellitus

[The Effects of Early Intensive Therapy on Islet Beta Cell Function and Long-Term Glycemia Control in Newly Diagnosed Type 2 Diabetic Patients with Different Fasting Plasma Glucose Levels.].

Characteristics and clinical significance of daily blood glucose profiles in patients with gestational diabetes mellitus monitored by continuous glucose monitoring system

The Characteristics of Blood Glucose Fluctuations in Patients with Fulminant Type 1 Diabetes Mellitus in the Stable Stage

A Randomized Study to Compare the Effects of Once-Weekly Dulaglutide Injection and Once-Daily Glimepiride on Glucose Fluctuation of Type 2 Diabetes Mellitus Patients: A 26-Week Follow-Up

Basal Insulin Reduces Glucose Variability and Hypoglycaemia Compared to Premixed Insulin in Type 2 Diabetes Patients: A Study Based on Continuous Glucose Monitoring Systems.

Real-time continuous glucose monitoring-guided glucose management in inpatients with diabetes receiving short-term continuous subcutaneous insulin infusion: a randomized clinical trial

Effects of intermittent high glucose on insulin release and insulin sensitivity in diabetic rats

The Effect of Simulating Insulin Pump with Insulin Lispro and Insulin Glargine on Diabetic Patients